Science & Research
New Frontiers in Science Distinguished Lectureship Program
FDA's New Frontiers in Science Distinguished Lectureship Program fosters expert scientific exchange between the scientific community and FDA. It represents an important part of FDA's efforts to expand the range of scientific professional development opportunities it provides its staff to ensure that the Agency has the skills and know-how required to modernize or develop new regulatory pathways for our products.
Supported by a cosponsorship agreement with the Health Research Alliance (HRA), a national alliance of nongovernmental, nonprofit funders of health research and training, the lectureship invites experts in cutting-edge science for a one- to three-day visit to FDA to deliver lectures, seminars, or short tutorials on their area of expertise and address the audience's questions.
HRA promotes open communication and collaboration among member organizations; provides comprehensive data and analysis about the funding of biomedical research and training by HRA member organizations; identifies gaps in funding and facilitates innovative grantmaking; and addresses issues key to accelerating research discovery and its translation.
Watch These Lectures on Leading-Edge Science
Cardiovascular Risk in Rheumatoid Arthritis and Implications for Treatment
by Joan M. Bathon, MD
Division of Rheumatology
- Systems Medicine, the Emergence of Transformational Technologies and Proactive P4 Medicine
by Lee Hood, MD PhD
President and Co-founder
Institute for Systems Biology
Emerging Strategies for the Early Detection of Cancer
by Sanjiv Gambhir, M.D., Ph.D., Professor of Radiology
Stanford University School of Medicine
Ethical Challenges Fueled by Innovation: Compassionate Use,
Personalized Medicine and Comparative Efficacy Research
by Arthur Caplan, PhD
Drs. William F and Virginia Connolly Mitty Chair
New York University
Lagone Medical Center